Graffeo R, Livraghi L, Pagani O, Goldhirsch A, Partridge AH, Garber JE. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Breast Cancer Research and Treatment. 2016 Dec;160(3):393-410. |
|
Tung N, Domchek SM, Stadler Z, Nathanson KL, Couch F, Garber JE, Robson ME. Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nature Reviews Clinical Oncology. 2016 Sep;13(9):581-8. |
|
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology:Breast and Ovarian. |
|
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Colorectal. |
|
Paluch SS, Cardoso F, Sessa C, Balmana J, Cardoso MJ, Gilbert F, Senkus E. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening. Annals of Oncology. 2016; 27(5), 103-110. |
Graffeo R, Livraghi L, Pagani O, Goldhirsch A, Partridge AH, Garber JE. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Breast Cancer Research and Treatment. 2016 Dec;160(3):393-410. |
|
Tung N, Domchek SM, Stadler Z, Nathanson KL, Couch F, Garber JE, Robson ME. Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nature Reviews Clinical Oncology. 2016 Sep;13(9):581-8. |
|
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology:Breast and Ovarian. |
|
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology:Colorectal. |
|
Paluch SS, Cardoso F, Sessa C, Balmana J, Cardoso MJ, Gilbert F, Senkus E. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening. Annals of Oncology. 2016; 27(5), 103-110. |
|